Redefinition of myocardial infarction: New challenges and opportunities

European Heart Journal

Volumn 27, Issue 20, 2006, Pages 2373-2375

  Roger, Véronique L ^a  

^a Department of Cardiovascular Diseases ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; DISEASE SEVERITY; EDITORIAL; FINLAND; HEALTH SURVEY; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; METHODOLOGY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION;

BIOLOGICAL MARKERS; COST OF ILLNESS; HUMANS; MYOCARDIAL INFARCTION; TROPONIN;

EID: 33749543724     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl226     Document Type: Editorial

References (11)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-1259.
2. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
3. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700.
4. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005;162:700, 764-773.
5. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-867.
6. Brown MS, Goldstein JL. Heart attacks: gone with the century? Science 1996;272:629.
7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
8. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-986.
9. Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Lehtonen A, Torppa J, Kuulasmaa K, Kesäniemi YA, Pyörälä K for the FINAMI Study Group. The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study. Eur Heart J 2006;27:2394-2399. First published on July 3, 2006, doi:10.1093/eurheartj/ ehl120.
10. Jaffe AS. Elevations in cardiac troponin measurements: false false-positives: the real truth. Cardiovasc Toxicol 2001;1:87-92.
11. Fox KA, Birkhead J, Wilcox R, Knight C, Barth J, British Cardiac Society Working Group. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004;90:603-609.